Companies researching Opdivo (nivolumab)

Opdivo, known generically as nivolumab, is an immunotherapy medication employed to treat multiple forms of cancer.

List of companies that research Opdivo (nivolumab)

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United States

Pharmaceutical Manufacturing

39k

$46B

Opdivo (nivolumab)

Country flag

United States

Hospitals and Health Care

1.4k

Opdivo (nivolumab)

Country flag

United States

Pharmaceutical Manufacturing

3.4k

$15M

Opdivo (nivolumab)

Country flag

United States

Business Consulting and Services

1.2k

Opdivo (nivolumab)

Country flag

United States

Business Consulting and Services

97

$18M

Opdivo (nivolumab)

Country flag

United States

Hospitals and Health Care

21k

$5.5B

Opdivo (nivolumab)

Country flag

France

Hospitals and Health Care

3k

Opdivo (nivolumab)

Country flag

United States

Non-profit Organizations

96

Opdivo (nivolumab)

Country flag

United States

Medical Practices

201

$36M

Opdivo (nivolumab)

Country flag

Netherlands

Research Services

620

Opdivo (nivolumab)

Showing top companies out of 13 that research Opdivo (nivolumab). Get the full list on TheirStack.

Frequently asked questions